Papers

2

Total Citations

17

H-Index

2

About

Carole Tournier is a pioneering researcher in pediatric pharmaceutical sciences, with a specialized focus on improving the acceptability and swallowability of solid oral dosage forms (SODFs) for children. Her work addresses a critical gap in drug development: making medications easier and safer for pediatric patients to take. Tournier’s major contributions include the development of a novel soft robotic pediatric in vitro swallowing device, which mimics the human swallowing mechanism to assess how mini-tablets and multiparticulates behave in a child’s throat. This innovative tool, detailed in her most-cited paper (2022, 13 citations), provides unprecedented insights into the physical factors affecting swallowability, reducing reliance on animal or human trials. She further advanced the field by demonstrating that binary mixtures of mini-tablets with pellets can significantly improve in vitro swallowability, as shown in her 2023 study (4 citations). Tournier’s work is notable for its direct impact on designing age-appropriate formulations, potentially transforming how combination products are delivered to children. With a growing citation record, her research is essential reading for scientists and clinicians aiming to enhance pediatric medication adherence and safety.

Research Focus

Key Achievements

2
H-Index
2
Papers
17
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
A novel soft robotic pediatric in vitro swallowing device to gain insights into the swallowability of mini-tablets
13 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Université de Bourgogne, Centre National de la Recherche Scientifique

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 18 days ago